Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ)
CNY 5.25
(-2.42%)
CNY 5.25
(-2.42%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 126.5 Million CNY | -18.68% |
| 2022 | 155.56 Million CNY | 1581.55% |
| 2021 | 9.25 Million CNY | -84.5% |
| 2020 | 59.7 Million CNY | -25.09% |
| 2019 | 79.7 Million CNY | 66.04% |
| 2018 | 48 Million CNY | 5.96% |
| 2017 | 45.3 Million CNY | -68.34% |
| 2016 | 143.1 Million CNY | -19.88% |
| 2015 | 178.61 Million CNY | 59.02% |
| 2014 | 112.31 Million CNY | 702.28% |
| 2013 | 14 Million CNY | 55.56% |
| 2012 | 9 Million CNY | 28.57% |
| 2011 | 7 Million CNY | -47.93% |
| 2010 | 13.44 Million CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 91.02 Million CNY | -30.04% |
| 2024 Q2 | 83.5 Million CNY | -5.65% |
| 2024 Q3 | 118.7 Million CNY | 42.16% |
| 2023 Q1 | 137.78 Million CNY | -11.43% |
| 2023 FY | 126.5 Million CNY | -18.68% |
| 2023 Q4 | 126.5 Million CNY | -6.32% |
| 2023 Q3 | 135.02 Million CNY | 51.56% |
| 2023 Q2 | 89.09 Million CNY | -35.34% |
| 2022 FY | 155.56 Million CNY | 1581.55% |
| 2022 Q1 | 168.83 Million CNY | 1724.93% |
| 2022 Q4 | 155.56 Million CNY | -3.82% |
| 2022 Q2 | 214.95 Million CNY | 27.32% |
| 2022 Q3 | 161.74 Million CNY | -24.76% |
| 2021 Q3 | 4.88 Million CNY | -19.05% |
| 2021 Q4 | 9.25 Million CNY | 89.2% |
| 2021 Q2 | 6.04 Million CNY | -53.59% |
| 2021 FY | 9.25 Million CNY | -84.5% |
| 2021 Q1 | 13.01 Million CNY | -78.2% |
| 2020 Q1 | 79.7 Million CNY | 0.0% |
| 2020 FY | 59.7 Million CNY | -25.09% |
| 2020 Q2 | 166.5 Million CNY | 108.91% |
| 2020 Q3 | 166.5 Million CNY | 0.0% |
| 2020 Q4 | 59.7 Million CNY | -64.14% |
| 2019 Q1 | 25 Million CNY | -47.92% |
| 2019 FY | 79.7 Million CNY | 66.04% |
| 2019 Q2 | 79.33 Million CNY | 217.34% |
| 2019 Q4 | 79.7 Million CNY | 54.51% |
| 2019 Q3 | 51.58 Million CNY | -34.98% |
| 2018 Q4 | 48 Million CNY | -19.6% |
| 2018 FY | 48 Million CNY | 5.96% |
| 2018 Q3 | 59.7 Million CNY | 0.0% |
| 2018 Q2 | 59.7 Million CNY | 70.09% |
| 2018 Q1 | 35.1 Million CNY | -22.52% |
| 2017 Q2 | 49.2 Million CNY | -58.34% |
| 2017 Q1 | 118.1 Million CNY | -17.47% |
| 2017 Q3 | 71.1 Million CNY | 44.51% |
| 2017 Q4 | 45.3 Million CNY | -36.29% |
| 2017 FY | 45.3 Million CNY | -68.34% |
| 2016 Q4 | 143.1 Million CNY | -52.19% |
| 2016 Q3 | 299.3 Million CNY | -6.51% |
| 2016 Q2 | 320.13 Million CNY | 75.55% |
| 2016 Q1 | 182.36 Million CNY | 2.1% |
| 2016 FY | 143.1 Million CNY | -19.88% |
| 2015 Q2 | 222.94 Million CNY | 61.77% |
| 2015 Q4 | 178.61 Million CNY | -8.34% |
| 2015 FY | 178.61 Million CNY | 59.02% |
| 2015 Q3 | 194.86 Million CNY | -12.6% |
| 2015 Q1 | 137.81 Million CNY | 22.7% |
| 2014 Q2 | 144.83 Million CNY | 160.97% |
| 2014 FY | 112.31 Million CNY | 702.28% |
| 2014 Q1 | 55.5 Million CNY | 296.43% |
| 2014 Q3 | 149.43 Million CNY | 3.18% |
| 2014 Q4 | 112.31 Million CNY | -24.84% |
| 2013 Q1 | 9 Million CNY | 0.0% |
| 2013 Q2 | 9 Million CNY | 0.0% |
| 2013 FY | 14 Million CNY | 55.56% |
| 2013 Q3 | 28 Million CNY | 211.11% |
| 2013 Q4 | 14 Million CNY | -50.0% |
| 2012 Q3 | 17 Million CNY | 0.0% |
| 2012 Q4 | 9 Million CNY | -47.06% |
| 2012 Q2 | 17 Million CNY | -32.0% |
| 2012 FY | 9 Million CNY | 28.57% |
| 2012 Q1 | 25 Million CNY | 257.14% |
| 2011 Q2 | 10 Million CNY | -18.18% |
| 2011 FY | 7 Million CNY | -47.93% |
| 2011 Q4 | 7 Million CNY | -30.0% |
| 2011 Q3 | 10 Million CNY | 0.0% |
| 2011 Q1 | 12.22 Million CNY | -9.09% |
| 2010 Q1 | - CNY | 0.0% |
| 2010 Q4 | 13.44 Million CNY | 0.0% |
| 2010 FY | 13.44 Million CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2009 Q2 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2009 Q3 | - CNY | 0.0% |
| 2008 Q4 | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 671.68 Million CNY | 81.167% |
| Zhejiang Zhenyuan Share Co., Ltd. | 54.96 Million CNY | -130.164% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 94.96 Million CNY | -33.202% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 419.53 Million CNY | 69.848% |
| Yifan Pharmaceutical Co., Ltd. | 812.04 Million CNY | 84.422% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | - CNY | -Infinity% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.64 Billion CNY | 95.224% |
| Boai NKY Medical Holdings Ltd. | 32.61 Million CNY | -287.864% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 21.25 Million CNY | -495.123% |